Zhitong Finance App News, Minimally Invasive Xintong-B (02160.HK) issued an announcement. As of the date of this announcement, the Group's VitaFOW® series transcatheter aortic valves and delivery systems have entered 35 countries and regions around the world, with a cumulative total of nearly 1,300 implants. Among them, the number of implants is expected to exceed 850 in 2025, an increase of nearly 350% over 2024. In the second half of 2025, thanks to the continued expansion of commercialization of VitaFow Liberty® in European countries after obtaining CE certification, and the continued increase in the share of emerging markets in Asia and Latin America, implantation volume increased by more than 170% compared to the first half of the year.

Zhitong Finance App News, Minimally Invasive Xintong-B (02160.HK) issued an announcement. As of the date of this announcement, the Group's VitaFOW® series transcatheter aortic valves and delivery systems have entered 35 countries and regions around the world, with a cumulative total of nearly 1,300 implants. Among them, the number of implants is expected to exceed 850 in 2025, an increase of nearly 350% over 2024. In the second half of 2025, thanks to the continued expansion of commercialization of VitaFow Liberty® in European countries after obtaining CE certification, and the continued increase in the share of emerging markets in Asia and Latin America, implantation volume increased by more than 170% compared to the first half of the year.